Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

229results about How to "Reduce constipation" patented technology

Compound feed for pregnant sows in expected date of delivery

InactiveCN103355557AImprove production performanceGuaranteed breast developmentAnimal feeding stuffTryptophanLactation
The invention discloses compound feed for pregnant sows in expected date of delivery. The feed is prepared by smashing and mixing following raw materials by weight: 55-65 parts of corn, 8-15 parts of soybean pulp, 2-10 parts of corn gluten powder, 3-8 parts of malt sprout, 0-3 parts of soybean oil, 2-8 parts of middlings, 3-5 parts of full-fat soybean, 0-8 parts of wheat bran, 0.4-0.6 part of a microelement premix, 0.4-0.6 part of a vitamin premix, 1.0-1.5 parts of calcium hydrophosphate, 0.2-0.4 part of edible salt, 0.5-1.0 part of stone powder, 0.2-0.5 part of lysine, 0-0.2 part of threonine, 0.08-0.1 part of tryptophan, 0.3-0.8 part of yeast culture, 0.1-0.12 part of choline and 0.1-0.4 part of magnesium sulfate. According to the feed, requirements of rapid growth of fetus in the latter half period of gestation of the sows are met, and reasonable birth weights and vitality are guaranteed; contraction functions of uterine and intestinal smooth muscles of the sows under the condition of high abdominal pressure are guaranteed; problems, namely difficult delivery, prolonged delivery, postpartum triad syndrome, and the like, occurred to the sows during delivery and lactation are reduced; and sow production performances are improved.
Owner:临夏州众惠猪业科技有限公司 +1

Composition and method for treatment of hepatic encephalopathy

InactiveUS20050142099A1Decrease plasma levelReduce constipationBiocideDigestive systemSide effectLactulose
The inventions provide an improved treatment for hepatic encephalopathy characterized by hyperammonemia and / or constipation, comprising the oral administration of polyethylene glycol (PEG) in amounts sufficient to reduce plasma levels of ammonia and / or to alleviate constipation. Preferably, the PEG is administered in combination with lactulose, which provides a palatable composition for the treatment of HE with excellent therapeutic benefits and reduced side effects as compared to lactulose alone.
Owner:HALOW GEORGE M

Beta-glucan-containing products, methods of making same, and uses therefor

InactiveUS20060228461A1Increase yield and purity of and yieldModerating responseDough treatmentMetabolism disorderChemistryBeta-glucan
Novel beta-glucan-containing products formed from cereals are described as are methods for producing such products, and uses for such products. In one preferred aspect, the invention relates to flour-like cereal products containing beta-glucan.
Owner:GRANATE SEED +1

Crosslinked polyallylamine or acid addition salt thereof, and use thereof for medical purposes

Disclosed is a crosslinked polyallylamine or an acid addition salt thereof which has both of high phosphoric acid adsorption ability and a low degree of swelling. Also disclosed is use of the crosslinked polyallylamine or the acid addition salt thereof for medical purposes. Specifically disclosed is a crosslinked polyallylamine or an acid addition salt thereof which is produced by copolymerizing allylammonium dihydrogen phosphate and an acid addition salt of N,N'-diallyl-1,3-diaminopropane in an amount of 5 to 25 mol% relative to the amount of allylammonium dihydrogen phosphate, and which hasa phosphoric acid adsorption amount of 2.7 to 5.0 mmol / g and a degree of swelling of 2.0 to 5.0. The crosslinked polyallylamine or the acid addition salt thereof is useful as a therapeutic or prophylactic agent for hyperphosphatemia or the like.
Owner:TORAY IND INC

Formula goat milk powder for infants and preparation method thereof

The invention firstly aims at providing formula goat milk powder for infants. The formula goat milk powder for the infants is prepared from the following raw materials in parts by weight: degreased goat milk powder, whole goat milk powder, concentrated goat whey protein powder, gangliosides, lactose, glucose syrup solids, milk fat, OPO structure grease, docosahexaenoic acid, arachidonic acid, a vitamin premix, a mineral substance premix, taurine, vegetable oil, compound probiotics and the like. According to the formula goat milk powder for the infants, provided by the invention, brain trophic factors including the gangliosides, the milk fat, the OPO structure grease and the compound probiotics and the like are added; particularly, the synergistic effect of the gangliosides, the docosahexaenoic acid and the arachidonic acid is utilized so that functional components of the formula goat milk powder for the infants are relatively close to those of breast milk; and furthermore, the brain development of the infants is further improved. The invention secondly aims at providing a preparation method of the formula goat milk powder for the infants, and the preparation method has the characteristics of simple process steps and easiness of controlling technical parameters, and is suitable for large-scale production.
Owner:HYPROCA NUTRITION CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products